USA Stem Cell Therapy Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Stem Cell Therapy market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Stem Cell Therapy market. Detailed analysis of key players, along with key growth strategies adopted by Stem Cell Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • CELGENE CORPORATION

    • ReNeuron Group plc

    • Virgin Health Bank

    • Biovault family

    • Precious Cells International Ltd

    • Mesoblast Ltd

    • Chiesi Pharmaceuticals

    • Seneca Biopharmaceuticals, Inc

    • Opexa Therapeutics, Inc

    • Pluristem Therapeutics Inc

    • STEMCELL Technologies Inc

    • ThermoGenesis Holdings, Inc

    • NuVasive

    • Cellular Engineering Technologies

    • BioTime, Inc

    By Type:

    • Autologous

    • Allogeneic

    By End-User:

    • Musculoskeletal Disorder

    • Wounds & Injuries

    • Cornea

    • Cardiovascular Diseases

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Stem Cell Therapy Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Stem Cell Therapy Market Size and Growth Rate of Autologous from 2016 to 2027

      • 1.3.2 USA Stem Cell Therapy Market Size and Growth Rate of Allogeneic from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Stem Cell Therapy Market Size and Growth Rate of Musculoskeletal Disorder from 2016 to 2027

      • 1.4.2 USA Stem Cell Therapy Market Size and Growth Rate of Wounds & Injuries from 2016 to 2027

      • 1.4.3 USA Stem Cell Therapy Market Size and Growth Rate of Cornea from 2016 to 2027

      • 1.4.4 USA Stem Cell Therapy Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

      • 1.4.5 USA Stem Cell Therapy Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Stem Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Stem Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Stem Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Stem Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Stem Cell Therapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Stem Cell Therapy by Major Types

      • 3.4.1 Market Size and Growth Rate of Autologous

      • 3.4.2 Market Size and Growth Rate of Allogeneic

    4 Segmentation of Stem Cell Therapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Stem Cell Therapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Stem Cell Therapy in Musculoskeletal Disorder

      • 4.4.2 Market Size and Growth Rate of Stem Cell Therapy in Wounds & Injuries

      • 4.4.3 Market Size and Growth Rate of Stem Cell Therapy in Cornea

      • 4.4.4 Market Size and Growth Rate of Stem Cell Therapy in Cardiovascular Diseases

      • 4.4.5 Market Size and Growth Rate of Stem Cell Therapy in Others

    5 Market Analysis by Regions

    • 5.1 USA Stem Cell Therapy Production Analysis by Regions

    • 5.2 USA Stem Cell Therapy Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Stem Cell Therapy Landscape Analysis

    • 6.1 West USA Stem Cell Therapy Landscape Analysis by Major Types

    • 6.2 West USA Stem Cell Therapy Landscape Analysis by Major End-Users

    7 South USA Stem Cell Therapy Landscape Analysis

    • 7.1 South USA Stem Cell Therapy Landscape Analysis by Major Types

    • 7.2 South USA Stem Cell Therapy Landscape Analysis by Major End-Users

    8 Middle West USA Stem Cell Therapy Landscape Analysis

    • 8.1 Middle West USA Stem Cell Therapy Landscape Analysis by Major Types

    • 8.2 Middle West USA Stem Cell Therapy Landscape Analysis by Major End-Users

    9 Northeast USA Stem Cell Therapy Landscape Analysis

    • 9.1 Northeast USA Stem Cell Therapy Landscape Analysis by Major Types

    • 9.2 Northeast USA Stem Cell Therapy Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 CELGENE CORPORATION

        • 10.1.1 CELGENE CORPORATION Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 ReNeuron Group plc

        • 10.2.1 ReNeuron Group plc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Virgin Health Bank

        • 10.3.1 Virgin Health Bank Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Biovault family

        • 10.4.1 Biovault family Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Precious Cells International Ltd

        • 10.5.1 Precious Cells International Ltd Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Mesoblast Ltd

        • 10.6.1 Mesoblast Ltd Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Chiesi Pharmaceuticals

        • 10.7.1 Chiesi Pharmaceuticals Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Seneca Biopharmaceuticals, Inc

        • 10.8.1 Seneca Biopharmaceuticals, Inc Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Opexa Therapeutics, Inc

        • 10.9.1 Opexa Therapeutics, Inc Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Pluristem Therapeutics Inc

        • 10.10.1 Pluristem Therapeutics Inc Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 STEMCELL Technologies Inc

        • 10.11.1 STEMCELL Technologies Inc Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 ThermoGenesis Holdings, Inc

        • 10.12.1 ThermoGenesis Holdings, Inc Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 NuVasive

        • 10.13.1 NuVasive Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 Cellular Engineering Technologies

        • 10.14.1 Cellular Engineering Technologies Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 BioTime, Inc

        • 10.15.1 BioTime, Inc Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Stem Cell Therapy Market Size and Growth Rate of Autologous from 2016 to 2027

    • Figure USA Stem Cell Therapy Market Size and Growth Rate of Allogeneic from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Stem Cell Therapy Market Size and Growth Rate of Musculoskeletal Disorder from 2016 to 2027

    • Figure USA Stem Cell Therapy Market Size and Growth Rate of Wounds & Injuries from 2016 to 2027

    • Figure USA Stem Cell Therapy Market Size and Growth Rate of Cornea from 2016 to 2027

    • Figure USA Stem Cell Therapy Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

    • Figure USA Stem Cell Therapy Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Stem Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Stem Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Stem Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Stem Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Stem Cell Therapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Stem Cell Therapy

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Stem Cell Therapy by Different Types from 2016 to 2027

    • Table Consumption Share of Stem Cell Therapy by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Autologous

    • Figure Market Size and Growth Rate of Allogeneic

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Stem Cell Therapy by Different End-Users from 2016 to 2027

    • Table Consumption Share of Stem Cell Therapy by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Musculoskeletal Disorder

    • Figure Market Size and Growth Rate of Wounds & Injuries

    • Figure Market Size and Growth Rate of Cornea

    • Figure Market Size and Growth Rate of Cardiovascular Diseases

    • Figure Market Size and Growth Rate of Others

    • Table USA Stem Cell Therapy Production by Regions

    • Table USA Stem Cell Therapy Production Share by Regions

    • Figure USA Stem Cell Therapy Production Share by Regions in 2016

    • Figure USA Stem Cell Therapy Production Share by Regions in 2021

    • Figure USA Stem Cell Therapy Production Share by Regions in 2027

    • Table USA Stem Cell Therapy Consumption by Regions

    • Table USA Stem Cell Therapy Consumption Share by Regions

    • Figure USA Stem Cell Therapy Consumption Share by Regions in 2016

    • Figure USA Stem Cell Therapy Consumption Share by Regions in 2021

    • Figure USA Stem Cell Therapy Consumption Share by Regions in 2027

    • Table West USA Stem Cell Therapy Consumption by Types from 2016 to 2027

    • Table West USA Stem Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure West USA Stem Cell Therapy Consumption Share by Types in 2016

    • Figure West USA Stem Cell Therapy Consumption Share by Types in 2021

    • Figure West USA Stem Cell Therapy Consumption Share by Types in 2027

    • Table West USA Stem Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table West USA Stem Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Stem Cell Therapy Consumption Share by End-Users in 2016

    • Figure West USA Stem Cell Therapy Consumption Share by End-Users in 2021

    • Figure West USA Stem Cell Therapy Consumption Share by End-Users in 2027

    • Table South USA Stem Cell Therapy Consumption by Types from 2016 to 2027

    • Table South USA Stem Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure South USA Stem Cell Therapy Consumption Share by Types in 2016

    • Figure South USA Stem Cell Therapy Consumption Share by Types in 2021

    • Figure South USA Stem Cell Therapy Consumption Share by Types in 2027

    • Table South USA Stem Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table South USA Stem Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Stem Cell Therapy Consumption Share by End-Users in 2016

    • Figure South USA Stem Cell Therapy Consumption Share by End-Users in 2021

    • Figure South USA Stem Cell Therapy Consumption Share by End-Users in 2027

    • Table Middle West USA Stem Cell Therapy Consumption by Types from 2016 to 2027

    • Table Middle West USA Stem Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Stem Cell Therapy Consumption Share by Types in 2016

    • Figure Middle West USA Stem Cell Therapy Consumption Share by Types in 2021

    • Figure Middle West USA Stem Cell Therapy Consumption Share by Types in 2027

    • Table Middle West USA Stem Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Stem Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Stem Cell Therapy Consumption Share by End-Users in 2016

    • Figure Middle West USA Stem Cell Therapy Consumption Share by End-Users in 2021

    • Figure Middle West USA Stem Cell Therapy Consumption Share by End-Users in 2027

    • Table Northeast USA Stem Cell Therapy Consumption by Types from 2016 to 2027

    • Table Northeast USA Stem Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Stem Cell Therapy Consumption Share by Types in 2016

    • Figure Northeast USA Stem Cell Therapy Consumption Share by Types in 2021

    • Figure Northeast USA Stem Cell Therapy Consumption Share by Types in 2027

    • Table Northeast USA Stem Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Stem Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Stem Cell Therapy Consumption Share by End-Users in 2016

    • Figure Northeast USA Stem Cell Therapy Consumption Share by End-Users in 2021

    • Figure Northeast USA Stem Cell Therapy Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of CELGENE CORPORATION

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CELGENE CORPORATION

    • Figure Sales and Growth Rate Analysis of CELGENE CORPORATION

    • Figure Revenue and Market Share Analysis of CELGENE CORPORATION

    • Table Product and Service Introduction of CELGENE CORPORATION

    • Table Company Profile and Development Status of ReNeuron Group plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ReNeuron Group plc

    • Figure Sales and Growth Rate Analysis of ReNeuron Group plc

    • Figure Revenue and Market Share Analysis of ReNeuron Group plc

    • Table Product and Service Introduction of ReNeuron Group plc

    • Table Company Profile and Development Status of Virgin Health Bank

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Virgin Health Bank

    • Figure Sales and Growth Rate Analysis of Virgin Health Bank

    • Figure Revenue and Market Share Analysis of Virgin Health Bank

    • Table Product and Service Introduction of Virgin Health Bank

    • Table Company Profile and Development Status of Biovault family

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biovault family

    • Figure Sales and Growth Rate Analysis of Biovault family

    • Figure Revenue and Market Share Analysis of Biovault family

    • Table Product and Service Introduction of Biovault family

    • Table Company Profile and Development Status of Precious Cells International Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Precious Cells International Ltd

    • Figure Sales and Growth Rate Analysis of Precious Cells International Ltd

    • Figure Revenue and Market Share Analysis of Precious Cells International Ltd

    • Table Product and Service Introduction of Precious Cells International Ltd

    • Table Company Profile and Development Status of Mesoblast Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mesoblast Ltd

    • Figure Sales and Growth Rate Analysis of Mesoblast Ltd

    • Figure Revenue and Market Share Analysis of Mesoblast Ltd

    • Table Product and Service Introduction of Mesoblast Ltd

    • Table Company Profile and Development Status of Chiesi Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chiesi Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Chiesi Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Chiesi Pharmaceuticals

    • Table Product and Service Introduction of Chiesi Pharmaceuticals

    • Table Company Profile and Development Status of Seneca Biopharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seneca Biopharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Seneca Biopharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Seneca Biopharmaceuticals, Inc

    • Table Product and Service Introduction of Seneca Biopharmaceuticals, Inc

    • Table Company Profile and Development Status of Opexa Therapeutics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Opexa Therapeutics, Inc

    • Figure Sales and Growth Rate Analysis of Opexa Therapeutics, Inc

    • Figure Revenue and Market Share Analysis of Opexa Therapeutics, Inc

    • Table Product and Service Introduction of Opexa Therapeutics, Inc

    • Table Company Profile and Development Status of Pluristem Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pluristem Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of Pluristem Therapeutics Inc

    • Figure Revenue and Market Share Analysis of Pluristem Therapeutics Inc

    • Table Product and Service Introduction of Pluristem Therapeutics Inc

    • Table Company Profile and Development Status of STEMCELL Technologies Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of STEMCELL Technologies Inc

    • Figure Sales and Growth Rate Analysis of STEMCELL Technologies Inc

    • Figure Revenue and Market Share Analysis of STEMCELL Technologies Inc

    • Table Product and Service Introduction of STEMCELL Technologies Inc

    • Table Company Profile and Development Status of ThermoGenesis Holdings, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ThermoGenesis Holdings, Inc

    • Figure Sales and Growth Rate Analysis of ThermoGenesis Holdings, Inc

    • Figure Revenue and Market Share Analysis of ThermoGenesis Holdings, Inc

    • Table Product and Service Introduction of ThermoGenesis Holdings, Inc

    • Table Company Profile and Development Status of NuVasive

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NuVasive

    • Figure Sales and Growth Rate Analysis of NuVasive

    • Figure Revenue and Market Share Analysis of NuVasive

    • Table Product and Service Introduction of NuVasive

    • Table Company Profile and Development Status of Cellular Engineering Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellular Engineering Technologies

    • Figure Sales and Growth Rate Analysis of Cellular Engineering Technologies

    • Figure Revenue and Market Share Analysis of Cellular Engineering Technologies

    • Table Product and Service Introduction of Cellular Engineering Technologies

    • Table Company Profile and Development Status of BioTime, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioTime, Inc

    • Figure Sales and Growth Rate Analysis of BioTime, Inc

    • Figure Revenue and Market Share Analysis of BioTime, Inc

    • Table Product and Service Introduction of BioTime, Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.